BioTissuePress Releases

Latest News

Press Releases

Dec 1, 2021

Amniox Donates $10,000 to American Diabetes Association to Further Scientific Research into Treatment Options for Chronic Wounds

Press Releases

Oct 13, 2021

TissueTech Grows Sales Force to Support Footprint Expansion

Press Releases

Oct 12, 2021

BioTissue Signs National Agreement with EyePro GPO to Afford Members Exclusive Treatment Options for Ocular Surface Disease and Disorders

Press Releases

Sep 14, 2021

Inaugural Leadership Summit brings together Key Opinion Leaders from Across the Clinical Spectrum to Share Best Practices on Regenerative Medicine

Press Releases

Jun 10, 2021

Amniox Launches New Complex Wound Management Campaign in Support of Wound Healing Awareness Month

Press Releases

May 10, 2021

BioTissue to Present Webinar in 3-D Showcasing New Treatment Regimen to Successfully Diagnose and Treat Mechanical Dry Eye

Press Releases

Apr 19, 2021

TissueTech Partners with Donate Life America to Raise Public Awareness about the Importance of Tissue Donation

Press Releases

Mar 8, 2021

TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain

Press Releases

Mar 1, 2021

TissueTech Receives U.S. Food and Drug Administration Clearance to Proceed with Clinical Study using Investigational New Drug TTBT01

References

Marston, WA, Lantis, JC, Wu, SC, et al. One‐year safety, healing and amputation rates of Wagner 3‐4 diabetic foot ulcers treated with cryopreserved umbilical cord (TTAX01). Wound Rep Reg. 2020; 1– 6. https://doi.org/10.1111/wrr.12809 Marston, W. A., Lantis, J. C., Wu, S. C., Nouvong, A., Lee, T.

http://www.woundcarestakeholders.org/images/documents/2017/Fact_Sheet-Economic_Burden_of_Wounds_10.5.17.pdf